Egypt Metabolic Disorders Drug Market Insights and In-Depth Analysis 2023-2028 with Types, Products and Key Players

Egypt Metabolic disorders drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The metabolic disorders drugs market consists of sales of metabolic disorders drugs and related services by entities (organizations, sole traders, and partnerships) that produce metabolic disorders drugs to treat metabolic diseases.

In 2017, among the world's 20 most populous countries, Egypt had the highest age-standardized rate of all diet-related deaths and DALYs. Diabetes and abdominal obesity prevalence in Egypt are high compared to global levels, but low compared with some MENA countries, particularly the Gulf Cooperation Council. The IDF estimates that 14.9% of the adult population in Egypt is currently diagnosed with diabetes and that USD219 was the mean annual diabetes-related spending per person in 2016.

Market Drivers

The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of developing countries such as Egypt, especially non-communicable diseases such as diabetes and obesity. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of metabolic disorders. These factors are expected to increase the patient pool, thereby driving the metabolic disorders drugs market during the forecast period in Egypt.

The IDF estimates that in 2016, there were 3.2mn cases of diabetes in adults that were undiagnosed. This is a concern, as there are numerous medical complications from diabetes, leading to considerable indirect healthcare costs. In 2016, diabetes accounted for 481,031 DALYs in Egypt, which is set to increase by 2030 to 879,976. The high prevalence of Metabolic Syndrome among middle-aged and elderly Egyptians with the documented high prevalence of chronic diseases in Egypt provides a place for market growth of metabolic drugs.

The presence of several approved metabolic disorders therapeutics drugs and increase in research and development activities and favorable government policies are considered a positive indicator for the growth of metabolic disorders therapeutics.

It is assumed that the market for metabolic disorders therapeutics is majorly hampered by the discontinuation of drugs coupled with stringent regulation procedures.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/140090/

Major Players

Egypt's metabolic disorders treatment market appears to be fragmented with the presence of several local and global companies including AstraZeneca, Boehringer Ingelheim EIPICO, Novartis, GSK, Pharco, Amoun Pharmaceutical Company, Eva Pharma, Pfizer, Hikma.

"For Your Diabetes & Heart Health" campaign is part of Boehringer Ingelheim's efforts to raise awareness on one of the most common diseases. The company is playing an active role in corporate social responsibility through this new campaign, while also providing treatment for a better quality of life.

The Egypt Metabolic Disorders Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Metabolic Disorders Drug market. This report explores all the key factors affecting the growth of the global Egypt Metabolic Disorders Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

To Know More About COVID-19 Impact On Egypt Metabolic Disorders Drug Market @ https://www.prudentmarkets.com/sample-request/140090/

By Drug Type

Drug type for metabolic diseases segments the market into Anti-Diabetics drugs, Anti-Thyroid Drugs, and Others such as (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

By Distribution Channel

By distribution channel, the market for metabolic disorders drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

By Route of Administration

Based on route of administration, the drug market is segmented into oral, parenteral, topical, and others

By Drug Classification

Based on the classification of drugs, the market has been segmented into Branded Drugs and Generic Drugs

Major Players

Egypt's metabolic disorders treatment market appears to be fragmented with the presence of several local and global companies including AstraZeneca, Boehringer Ingelheim EIPICO, Novartis, GSK, Pharco, Amoun Pharmaceutical Company, Eva Pharma, Pfizer, Hikma.

"For Your Diabetes & Heart Health" campaign is part of Boehringer Ingelheim's efforts to raise awareness on one of the most common diseases. The company is playing an active role in corporate social responsibility through this new campaign, while also providing treatment for a better quality of life.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/140090/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Egypt Metabolic Disorders Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Egypt Metabolic Disorders Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Egypt Metabolic Disorders Drug market
Chapter 2: Exclusive Summary - the basic information of the Egypt Metabolic Disorders Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Egypt Metabolic Disorders Drug
Chapter 4: Presenting the Egypt Metabolic Disorders Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Egypt Metabolic Disorders Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/140090/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Egypt Metabolic Disorders Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.